Product Name: Quick-Neuron™ Mixed – Human iPSC-derived Neurons (F, 67 yr) – Alzheimer’s Disease
Quantity: ~1M viable cells
CIRM Line ID: CW50115
Disease: Alzheimer’s Disease
Gender: Female
Sampled age: 67
Ethnicity: Caucasian, Latino

SKU: MN-SeV-CW50115 Categories: , ,


Elixirgen Scientific’s proprietary transcription factor-based technology allows rapid and reproducible differentiation of human iPSCs into neurons without sacrificing the purity of the cells. Our Quick-Neuron™ Mixed – Human iPSC-derived Neurons exhibit typical neuronal morphology with outgrowing neurites and express markers characteristic of a variety of neuronal subtypes, including the pan-neuronal marker tubulin beta 3 class III (TUBB3), the glutamatergic neuron marker vesicular glutamate transporter 1 (vGLUT1), the cholinergic neuron marker choline acetyltransferase (ChAT), the dopaminergic neuron marker tyrosine hydroxylase (TH), the serotonergic neuron marker tryptophan hydroxylase 2 (TPH2), and the GABAergic neuron marker glutamate decarboxylase 1, 67 kDa isoform (GAD1/GAD67). When thawed and maintained according to the instructions in the User Guide, the iPSC-derived neurons are viable long-term and are suitable for a variety of characterization and neurotoxicity assays.


  • Functionally validated 
  • Highly pure population  
  • No genetic footprint 

Protocol Outline

ipsc neuron workflow

From Day 10, users may maintain differentiated neurons in the maintenance medium best suited for their needs, though we recommend Quick-Neuron™ Mixed – Maintenance Medium.


ipsc neurons

Quick-Neuron™ Mixed cultures expressing the pan-neuronal marker TUBB3 and glutamatergic neuron marker vGLUT1 on Day 7 post-thaw.

ipsc neurons bf

Quick-Neuron™ Mixed cultures on Days 1 through 10 post-thaw (4x and 10x objective).

User Guides

Donor Information

Demographic (source: CIRM) Description ALZHEIMER DISEASE; AD
Affected Status Yes
Product iPSC
Source PBMC
Sex Female
Age at Sampling 67 YR
Race Caucasian
Ethnicity Hispanic or Latino
Publications Cited 0
dbGap No
Biopsy Source Blood
Collection Alzheimer’s Disease
Cell Type Stem Cell
Tissue Type Induced pluripotent stem cell
Transformant Episomal
Species sapiens
Common Name human
Detailed Clinical Data false
Clinical data (source: CIRM) AlzheimersDisease AlzheimersDisease
Typical_probable_AD_diagnosis Yes
Age_at_onset_of_dementia 58
Atypical_probable_AD:_Progressive aphasia No
Atypical_probable_AD:_Posterior cortical_atrophy No
APOE_e4_carrier Yes
Amyloid_biomarker_test_conducted_(CSF_or_amyloid_P Yes
Height_(inches) 59
Weight_(pounds) 136



Goparaju, Sravan Kumar, Kazuhisa Kohda, Keiji Ibata, Atsumi Soma,Yukhi Nakatake, Tomohiko Akiyama, Shunichi Wakabayashi, Misako Matsushita, Miki Sakota, Hiromi Kimura, Michisuke Yuzaki, Shigeru B. H. Ko, and Minoru S. H. Ko. ” Rapid Differentiation of Human Pluripotent Stem Cells into Functional Neurons by MRNAs Encoding Transcription Factors.” Scientific Reports. Nature Publishing Group, 13 Feb. 2017. Web. 16 Feb. 2017. doi:10.1038/srep42367


Products will be shipped through FedEx Corporation’s services, and are available for purchase internationally. Shipping cost will be estimated, calculated, and displayed along with your order total in the checkout screen.


Payment will be processed by the Elixirgen Scientific store page’s Paypal plugin. The Paypal plugin offers payment through multiple credit and banking services, as well as Paypal itself. If there are any questions regarding alternative payment methods or bulk purchases, please email [email protected]


Not for medical diagnostic or clinical use. For in vitro use only. By use of this product, the recipient agrees to be bound by the terms of this limited use statement. This product may not be further sold or transferred by the recipient and may be used only by the recipient. Elixirgen Scientific makes no representations or warranties of any kind, either expressed or implied, including as to merchantability or fitness for a particular purpose with regards to this product. The terms of this agreement shall be governed under the laws of the State of Maryland, USA.